{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:25:44Z","timestamp":1761395144776},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["FAPESP"],"award-info":[{"award-number":["FAPESP"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Funda\u00e7\u00e3o de Apoio ao Ensino, Pesquisa e Assist\u00eancia do Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo (FAEPA)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jpba.2017.11.041","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T11:11:00Z","timestamp":1513595460000},"page":"442-447","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers"],"prefix":"10.1016","volume":"149","author":[{"given":"Natal\u00edcia de Jesus","family":"Antunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauro","family":"Wichert-Ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Barbosa","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Della Pasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veriano","family":"Alexandre Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo Massaiti","family":"Takayanagui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paula","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera Lucia","family":"Lanchote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.11.041_bib0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cca.2014.06.002","article-title":"Advances in anti-epileptic drug testing","volume":"436","author":"Krasowski","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2017.11.041_bib0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0378-4347(99)00531-9","article-title":"Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine","volume":"738","author":"Volosov","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.11.041_bib0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/cp.1999.v66.103170001","article-title":"Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy chinese subjects","volume":"66","author":"Volosov","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2017.11.041_bib0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2165\/00003088-200342120-00002","article-title":"Clinical pharmacokinetics of oxcarbazepine","volume":"42","author":"May","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2017.11.041_bib0025","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1111\/j.1528-1157.1994.tb05967.x","article-title":"Oxcarbazepine: preclinical anticonvulsivant profile and putative mechanisms of action","volume":"35","author":"Schmutz","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2017.11.041_bib0030","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/dmd.109.030593","article-title":"Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine","volume":"39","author":"Flesch","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2017.11.041_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00003088-199630060-00003","article-title":"Measument and analysis of unbound drug concentrations","volume":"30","author":"Wright","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2017.11.041_bib0040","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1002\/jps.21658","article-title":"Drug metabolism influence of plasma protein binding on pharmacodynamics: estimation of in vivo receptor affinities of blockers using a new mechanism-based PK \u2013PD modelling approach","volume":"98","author":"Van Steeg","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2017.11.041_bib0045","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/aps.2013.78","article-title":"Stereoselective binding of chiral drugs to plasma proteins","volume":"34","author":"Shen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpba.2017.11.041_bib0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00315422","article-title":"Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia","volume":"39","author":"Patsalos","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2017.11.041_bib0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00870993","article-title":"Use of saliva for monitoring oxcarbazepine therapy in epileptic patients","volume":"31","author":"Klitgaard","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2017.11.041_bib0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/bdd.716","article-title":"Binding of licarbazepine enantiomers to mouse and human plasma proteins","volume":"366","author":"Fortuna","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jpba.2017.11.041_bib0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/chir.22231","article-title":"Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS\/MS: application in a pharmacokinetic study","volume":"903","author":"Antunes","year":"2013","journal-title":"Chirality"},{"key":"10.1016\/j.jpba.2017.11.041_bib0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.eplepsyres.2011.05.013","article-title":"Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with partial-onset seizures","volume":"96","author":"Perucca","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jpba.2017.11.041_bib0075","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.jchromb.2011.07.019","article-title":"Development and validation of an enantioselective liquid-chromatography\/tandem mass spectrometry method for the separation and quantification of eslicarbazepine acetate, eslicarbazepine, R-licarbazepine and oxcarbazepine in human plasma","volume":"879","author":"Loureiro","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.11.041_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00228-015-1970-4","article-title":"Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers","volume":"72","author":"Antunes","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2017.11.041_bib0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.chroma.2013.09.078","article-title":"Accuracy assessment on the analysis of unbound drug in plasma by comparing traditional centrifugal ultrafiltration with hollow fiber centrifugal ultrafiltration and application in pharmacokinetic study","volume":"1318","author":"Zhang","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.11.041_bib0090","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1039\/c3an01116j","article-title":"Correlation of in vitro and in vivo plasma protein binding using ultracentrifugation and UPLC-tandem mass spectrometry","volume":"138","author":"Srikanth","year":"2013","journal-title":"Analyst"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517319805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517319805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T21:00:19Z","timestamp":1719694819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517319805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":18,"alternative-id":["S0731708517319805"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.11.041","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}